-
Re: Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial Originally developed as an immunosuppressant for organ transplant patients, it has found new life as a potential anti-aging drug. Rapamycin has not been approved for such use in humans,…
Verla Montana
Verla_Montana
Joined: Mon May 16 06:09:19 UTC 2022
Follow